Inhibition of FAK or Src also partially impaired RSPO2-promoted cancer cell proliferation and migration, respectively, indicating that FAK/Src mutual activation in RSPO2-overexpressing tumor cells may synergistically promote tumor progression. The gene discussed is PTK2; the disease is neoplasm.